MedTrace Logo

The PRESSURE CABG Cardiac Surgery Trial

NCT04197700 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2024-09-19

No results posted yet for this study

Summary

This study will be a pragmatic, prospective, single-centre, unit-based cluster crossover, open-label registry trial. The cardiac surgical intensive care unit (CSICU) will be cluster assigned to alternating MAP targets in 6-month blocks in a sequence. Additional sites across Alberta may be added, as necessary.

Conditions

Interventions

OTHER

Target MAP Management

Target MAP Management

Sponsors & Collaborators

  • Canadian VIGOUR Centre

    collaborator OTHER

  • University of Alberta

    lead OTHER

Principal Investigators

  • Sean van Diepen, MD · University of Alberta

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2024-05-01
Completion
2024-05-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04197700 on ClinicalTrials.gov